1 question on the conference call.....OMG. Wall Street is clearly categorizing Vical as roadkill. If they ever get something on the board it will bring a big pop, but right now, given the zero corporate credibility the bet is on nothing happening. Man would a CyMVectin partnership look good about now. A buyout would be even better as it is clear that's the only way to get rid of Vijay.